Literature DB >> 28747387

Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas.

Masanori Murakami1, Takanobu Yoshimoto2, Kazuhiko Nakabayashi3, Yujiro Nakano1, Takahiro Fukaishi1, Kyoichiro Tsuchiya1, Isao Minami1, Ryotaro Bouchi1, Kohji Okamura4, Yasuhisa Fujii5, Koshi Hashimoto1,6, Ken-Ichiro Hata3, Kazunori Kihara5, Yoshihiro Ogawa1,7,8.   

Abstract

The pathophysiology of aldosterone-producing adenomas (APAs) has been investigated via genetic approaches and the pathogenic significance of a series of somatic mutations, including KCNJ5, has been uncovered. However, how the mutational status of an APA is associated with its molecular characteristics, including its transcriptome and methylome, has not been fully understood. This study was undertaken to explore the molecular characteristics of APAs, specifically focusing on APAs with KCNJ5 mutations as opposed to those without KCNJ5 mutations, by comparing their transcriptome and methylome status. Cortisol-producing adenomas (CPAs) were used as reference. We conducted transcriptome and methylome analyses of 29 APAs with KCNJ5 mutations, 8 APAs without KCNJ5 mutations and 5 CPAs. Genome-wide gene expression and CpG methylation profiles were obtained from RNA and DNA samples extracted from these 42 adrenal tumors. Cluster analysis of the transcriptome and methylome revealed molecular heterogeneity in APAs depending on their mutational status. DNA hypomethylation and gene expression changes in Wnt signaling and inflammatory response pathways were characteristic of APAs with KCNJ5 mutations. Comparisons between transcriptome data from our APAs and that from normal adrenal cortex obtained from the Gene Expression Omnibus suggested similarities between APAs with KCNJ5 mutations and zona glomerulosa. The present study, which is based on transcriptome and methylome analyses, indicates the molecular heterogeneity of APAs depends on their mutational status. Here, we report the unique characteristics of APAs with KCNJ5 mutations.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  adenoma; adrenal cortex; gene expression; molecular genetics

Mesh:

Substances:

Year:  2017        PMID: 28747387     DOI: 10.1530/ERC-17-0117

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  5 in total

1.  In situ metabolomics of aldosterone-producing adenomas.

Authors:  Masanori Murakami; Yara Rhayem; Thomas Kunzke; Na Sun; Annette Feuchtinger; Philippe Ludwig; Tim Matthias Strom; Celso Gomez-Sanchez; Thomas Knösel; Thomas Kirchner; Tracy Ann Williams; Martin Reincke; Axel Karl Walch; Felix Beuschlein
Journal:  JCI Insight       Date:  2019-09-05

2.  Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.

Authors:  Andrea G Maria; Mari Suzuki; Annabel Berthon; Crystal Kamilaris; Andrew Demidowich; Justin Lack; Mihail Zilbermint; Fady Hannah-Shmouni; Fabio R Faucz; Constantine A Stratakis
Journal:  Am J Hypertens       Date:  2020-02-22       Impact factor: 3.080

Review 3.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

4.  Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.

Authors:  Jung Soo Lim; Samuel W Plaska; Juilee Rege; William E Rainey; Adina F Turcu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

5.  Cellular Senescence in Human Aldosterone-Producing Adrenocortical Cells and Related Disorders.

Authors:  Jacopo Pieroni; Yuto Yamazaki; Xin Gao; Yuta Tezuka; Hiroko Ogata; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Biomedicines       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.